Welcome to Pradaxa-lawsuit.org. Our goal is to provide relevant, up-to-date information about the process involved in pursuing a claim against the manufacturer of Pradaxa, Boehringer Ingelheim Pharmaceutical Corporation, for injuries sustained by patients using that product. In order to help our visitors understand the big picture involved in that process we feel it is helpful to spend some time on background information.
Introduced in 2010, the anticoagulant Pradaxa (dabigitran) was touted (in muti-million dollar ad campaigns) as a safer and easier alternative to the well-known drug Coumadin (warfarin) for preventing strokes in patients with atrial fibrillation, or irregular heartbeat. Additionally the drug promised to reduce the need for frequent testing and restrictions on eating certain foods that were common with the use of Coumadin. Not surprisingly millions of patients switched to Pradaxa with over 1.1 million prescriptions written in the first two years.
Pradaxa Side Effects
Unfortunately, Pradaxa turned out to be less than the superior blood thinner it was advertised to be. Specifically, what is clear is that Pradaxa significantly increases the risk for uncontrolled bleading and, unlike the warfarin based blood thinners, there is no antidote to Pradaxa hemorrhaging. Additionally, researchers have found that patients taking Pradaxa have a 33 per cent higher risk of heart attack over those taking Coumadin.
Misconduct By Manufacturer
It goes without saying that every patient that uses a drug product trust that the manufacturer of that drug has rigorously tested the drug prior to marketing it to the public and that they have been forthcoming with any adverse information their in-house research suggests could be harmful to their product users. It has been alleged that Boehringer Ingelheim Corporation failed to adequately research Pradaxa side effects or worse was fully aware of the most common Pradaxa side effects yet failed to warn their potential users about these serious problems. As a result statistics suggest that thousands of Pradaxa patients have experienced adverse events and nearly 600 deaths are suspected to have been caused by the drug.
Given the evidence that has emerged since the introduction of Pradaxa that the drug can cause serious, often fatal side effects, it is not surprising that on December 11, 2011, only one year after its introduction, the FDA issued a safety alert for Pradaxa and announced that it would conduct a new round of safety reviews on the product. The European Medicines Agency, which is akin to the FDA, ordered the manufacturer to set specific parameters for the drug's use.
Pradaxa patients are stunned over the revelations that this massive multi-national drug company would so casually risk the health or even the life of its patients for profit. Not surprisingly many have chosen to file suit not only because they need the financial assistance to deal with their injuries but just as importantly to send a message to the manufacturer. On the pages that follow we will examine the most important factors in helping you or your loved one make the decision to pursue a claim against the manufacturer of Pradaxa, will also provide you with information to assist you in the selection of a law firm and will provide you with ability to consult with a Pradaxa attorney at no charge. Thank you for visiting Pradaxa-lawsuit.org.